NM_014629.4:c.2144-5243A>C
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_014629.4(ARHGEF10):c.2144-5243A>C variant causes a intron change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_014629.4 intron
Scores
Clinical Significance
Conservation
Publications
- autosomal dominant slowed nerve conduction velocityInheritance: AD, Unknown Classification: SUPPORTIVE, LIMITED Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Orphanet
- hereditary peripheral neuropathyInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- peripheral neuropathyInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_014629.4. You can select a different transcript below to see updated ACMG assignments.
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ARHGEF10 | TSL:1 MANE Select | c.2144-5243A>C | intron | N/A | ENSP00000340297.3 | O15013-5 | |||
| ARHGEF10 | TSL:1 | c.2216-5243A>C | intron | N/A | ENSP00000431012.1 | O15013-6 | |||
| ARHGEF10 | TSL:1 | c.2030-5243A>C | intron | N/A | ENSP00000427909.1 | O15013-7 |
Frequencies
GnomAD3 genomes AF: 0.00 AC: 0AN: 152046Hom.: 0 Cov.: 33
GnomAD4 genome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 152046Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74262
ClinVar
Not reported inComputational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.